Cargando…

Cell hierarchies in colorectal cancer: focus on APC and BRAF

Detalles Bibliográficos
Autores principales:	Morkel, Markus, Riemer, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580056/ https://www.ncbi.nlm.nih.gov/pubmed/26425654

Ejemplares similares

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
por: Morkel, Markus, et al.
Publicado: (2015)

APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers
por: Fennell, Lochlan J., et al.
Publicado: (2020)

Combination drug development in BRAF mutant colorectal cancer
por: Lam, Michael, et al.
Publicado: (2018)

The importance of APC
por: Ablamunits, Vitaly
Publicado: (2005)

Targeting parallel bypass signaling to combat adaptive resistance to BRAF inhibition in colorectal cancer
por: Gao, Chenxi, et al.
Publicado: (2018)

Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells
por: King, Lauren E., et al.
Publicado: (2016)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

The APC/C and CK1 in the developing brain
por: Penas, Clara, et al.
Publicado: (2015)

Does BRAF Mutation and Extracellular Signal Regulated Kinase Expression in Patients With Colorectal Cancer Have Any Prognostic Significance?
por: Baek, Moo Jun
Publicado: (2015)

APC: the toll road to continued high quality communication
por: Perbal, Bernard
Publicado: (2004)

BRAF Mutation in Colorectal Cancer: An Update
por: Barras, David
Publicado: (2015)

Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

Heterozygous APC germline mutations impart predisposition to colorectal cancer
por: Preisler, Livia, et al.
Publicado: (2021)

Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer
por: Peng, Huan, et al.
Publicado: (2023)

BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells
por: Goulielmaki, Maria, et al.
Publicado: (2016)

Modeling the Effect of APC Truncation on Destruction Complex Function in Colorectal Cancer Cells
por: Barua, Dipak, et al.
Publicado: (2013)

APC-driven actin nucleation powers collective cell dynamics in colorectal cancer cells
por: Baro, Lautaro, et al.
Publicado: (2023)

Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
por: Riemer, Pamela, et al.
Publicado: (2017)

Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer
por: Figer, A, et al.
Publicado: (2001)

Meta-analysis of the association between APC promoter methylation and colorectal cancer
por: Ding, Zhenyu, et al.
Publicado: (2015)

Role of APC and DNA mismatch repair genes in the development of colorectal cancers
por: Narayan, Satya, et al.
Publicado: (2003)

A nutrient-sensing pathway activated in APC-driven colorectal cancer
Publicado: (2014)

APC Mutations Are Not Confined to Hotspot Regions in Early-Onset Colorectal Cancer
por: Aitchison, Alan, et al.
Publicado: (2020)

Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy
por: Yang, Xiuyan, et al.
Publicado: (2021)

Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer
por: Shailes, Hannah, et al.
Publicado: (2022)

Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer
por: Feng, Fen, et al.
Publicado: (2022)

The implication of BRAF mutation in advanced colorectal cancer
por: O’Riordan, Emma, et al.
Publicado: (2021)

APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells
por: Faux, Maree C., et al.
Publicado: (2021)

The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis
por: Ghazvini, Mehrnaz, et al.
Publicado: (2013)

Cytoskeletal Control and Wnt Signaling—APC’s Dual Contributions in Stem Cell Division and Colorectal Cancer
por: Juanes, M. Angeles
Publicado: (2020)

Late Effects: Focus on Adolescent and Young Adult Cancer Survivors
por: Hallquist Viale, Pamela
Publicado: (2016)

EphB6 overexpression and Apc mutation together promote colorectal cancer
por: Xu, Dan, et al.
Publicado: (2016)

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018)

Case Report: Coinheritance of Germline Mutations in APC and BRCA1 in Colorectal Cancer
por: Huang, Wei, et al.
Publicado: (2021)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021)

Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer
por: Chun, Sung Kook, et al.
Publicado: (2022)

Can we establish a hierarchy among trastuzumab biosimilar candidates?
por: Pivot, Xavier, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b9us4paetimk56vuul21s37j6h